DeutschNewstral
Article
jdsupra.com on 2016-10-12 15:50
Amgen v. Apotex: Amgen Appeals Non-Infringement Judgment in Filgrastim/Pegfilgrastim Dispute
Related news
- Sandoz Initiates Declaratory Judgment Action Against Amgen Concerning Manufacturing of Filgrastim and Pegfilgrastim Biosimilarsjdsupra.com
- Breaking News: Summary Judgment of Non-Infringement for Sandoz in Filgrastim/Pegfilgrastim Casejdsupra.com
- Litigation Update: Case Management Statement in Amgen v. Sandoz (filgrastim, pegfilgrastim)jdsupra.com
- Breaking News: Apotex Does not Infringe Amgen’s Filgrastim and Pegfilgrastim Patent; Apotex is Permanently Enjoined From Launch Until It Provides 180 Days’ Noticejdsupra.com
- Amgen v. Sandoz: Final Judgment of Non-Infringement: Clearance for Biologics Still Being Finalized at the Time of Judgment?jdsupra.com
- Amgen v. Hospira: Hospira Files a Motion for Summary Judgment of Non-Infringementjdsupra.com
- Amgen and Accord End Filgrastim, Pegfilgrastim Biosimilar Litigationjdsupra.com
- Amgen v. Sandoz: Pegfilgrastim Litigation Updatejdsupra.com
- Amgen v. Apotex: Federal Circuit Oral Argument Setjdsupra.com
- Amgen Sues Sandoz Over Biosimilar Version of NEULASTA® (pegfilgrastim)jdsupra.com
- Magistrate Judge Recommends Dismissal of Amgen v. Coherus (Pegfilgrastim) Suitjdsupra.com
- Summary Judgment Practice Scheduled in Amgen v. Hospira Pegfilgrastim Casejdsupra.com
- Briefing Complete in Appeal in Amgen v. Apotexjdsupra.com
- Federal Circuit Issues Mandate in Amgen v. Apotexjdsupra.com
- Supreme Court Denies Cert. in Apotex v. Amgenjdsupra.com
- Breaking News: CAFC Affirms in Amgen v. Apotexjdsupra.com
- Solicitor General Supports Cert in Amgen v. Sandoz, Supreme Court Denies Cert in Amgen v. Apotexjdsupra.com
- Amgen and Hospira Square Off Over BPCIA Private Right of Action After Amgen v. Apotex Rulingjdsupra.com
- Filgrastim, pegfilgrastim biosimilar litigation updatesjdsupra.com
- Amgen Sues Pfizer and Hospira for Patent Infringement related to Hospira’s Filgrastim Biosimilarjdsupra.com